Elevated serum lipoprotein(a) level is an independent marker of severity of thoracic aortic atherosclerosis

Chest

Volumn 121, Issue 5, 2002, Pages 1589-1594

  Peltier, Marcel ^a   Peltier, Micheèle C Iannetta ^a   Sarano, Maurice E ^b   Lesbre, Jean Philippe M ^a   Colas, Jean Laurent ^a   Tribouilloy, Christophe M ^a  

^a South Hospital   (France)

^b MAYO CLINIC   (United States)

Author keywords

Atherosclerotic plaque; Lipoprotein A; Thoracic aorta; Transesophageal echocardiography

Indexed keywords

LIPOPROTEIN A;

ADULT; AGED; ANGIOCARDIOGRAPHY; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; BODY MASS; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SMOKING; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 0036252687     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.121.5.1589     Document Type: Article

References (45)

1. Lipoprotein(a) levels and risk of coronary heart disease in men: The Lipids Research Clinics Coronary Primary Prevention trial
2. Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease
3. A prospective investigation of elevated lipoprotein(a) detected by electrophoresis and cardiovascular disease in women: The Framingham Heart study
4. Lp(a) is an independent, discriminating risk factor for premature peripheral atherosclerosis among white men
5. Lp(a) distribution in a French Canadian population and its relation to intermittent claudication (the Quebec Cardiovascular Study)
6. Lp(a) lipoprotein as a risk factor for coronary artery disease and cerebral infarction
7. Lipoprotein(a) as a strong indicator for cerebrovascular disease
8. Elevated serum lipoprotein(a) is a risk factor for clinical recurrence after balloon coronary angioplasty
9. Risk factors for restenosis after percutaneous transluminal coronary angioplasty: Role of lipoprotein(a)
10. Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients
11. Lipoprotein(a) and accelerated coronary artery disease in cardiac transplant recipients
12. Serum lipoprotein(a) as a risk factor for thoracic aortic atherosclerosis in subjects aged >40 years
13. Recognition and embolic potential of intraaortic atherosclerotic debris
14. Aortic atherosclerotic plaques as a source of systemic embolism
15. Noninvasive prediction of coronary artery disease by transesophageal echocardiographic detection of thoracic aortic plaque in valvular heart disease
16. Serum lipoproteins in children and methods for study
17. Measurement of proteins with the Behring Nephelometer: A multicenter evaluation
18. Evaluation du risque coronaire: Une nouvelle technique de dosage de la lipoproteine (a)
19. Fibrinogen is an independent marker for thoracic aortic atherosclerosis
20. Angina, coronary artery disease in patient with valvular disease: A prospective study
21. Elevated serum lipoprotein(a) is a risk factor for atrial thrombus in patients with chronic atrial fibrillation: A transesophageal echocardiographic study
22. Lipoprotein(a) clinical approach to a unique atherogenic lipoprotein
23. Structural and functional polymorphism of lipoprotein(a): Biological and clinical implications
24. Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: Prospective results from the Bruneck study
25. Lipoprotein(a) concentration and apolipoprotein(a) size: A synergistic role in advances atherosclerosis?
26. Lipoprotein(a) and coronary heart disease risk: A nested case-control study of the Helsinki Heart Study participants
27. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population-based study
28. Lipoprotein(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: Results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS)
29. A prospective study of lipoprotein(a) and the risk of myocardial infarction
30. Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women
31. Is a lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study
32. Lipoprotein(a) and coronary heart disease: Meta-analysis of prospective studies
33. Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a)
34. Plasma Lp(a) levels correlated with number, severity, and length-extension of coronary lesions in male patients undergoing coronary atherosclerosis
35. Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients
36. Correlation of thoracic aortic atherosclerotic plaque detected by transesophageal echocardiography and cardiovascular risk factors
37. The role of lipoprotein(a) in atherogenesis and thrombosis
38. Oxidative modification of lipoprotein(a) and the effect of beta-carotene
39. Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis
40. Lp(a) lipoprotein and pre-Β1-lipoprotein in patients with coronary heart disease
41. Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a)
42. Should we measure lipoprotein Lp(a)?
43. Novel risk factors for atherosclerosis
44. High reproducibility in the interpretation of intraoperative transesophageal echocardiographic evaluation of aortic atheromatous disease
45. Secular trends in coronary atherosclerosis: Analysis in patients with valvular regurgitation